Methods and compositions for treating and preventing signs or symptoms of eye disease
View Patent ↗Compositions and methods for the treatment and prevention of at least one of a sign and a symptom associated with an eye disease are disclosed. Preferred compositions could comprise a liquid formulation including Cineraria maritima and at least one of a nonsteroidal anti-inflammatory drug, a carnosine, and a cannabinoid.
1. A method of treating cataracts in a human in need thereof comprising:
preparing a Cineraria maritima extract using at least one of a dry portion, a fresh succus portion, a fresh emulsified portion, and a liquefied portion of a Cineraria maritima plant;
adding acetylsalicyclic acid, N-acetylcarnosine and purified delta-9-tetrahydrocannabinol to the Cineraria maritima extract to produce an ophthalmic composition; and
administering a therapeutically effective amount of the ophthalmic composition into the eye of the human in need thereof.
2. The method of claim 1 , wherein administering the therapeutically effective amount comprises administering the ophthalmic composition as an eye drop.
3. The method of claim 1 , wherein administering the therapeutically effective amount comprises placing an ocular insert in an eye of the human.
4. The method of claim 1 , wherein adding acetylsalicyclic acid, N-acetylcarnosine and purified delta-9-tetrahydrocannabinol to the Cineraria maritima extract comprises adding 0.05-1% acetylsalicylic acid, 1% N-acetylcarnosine, and 1% Cannabis Sativa L.
5. The method of claim 4 , wherein the ophthalmic composition comprises between 0.0001 and 10 vol %, inclusive, of each of the 0.05-1% acetylsalicylic acid, the 1% N-acetylcarnosine and the 1% Cannabis Sativa L.
6. The method of claim 1 , further comprising adding at least one of a buffer, a viscolizer, and a preservative to the Cineraria maritima extract to produce the ophthalmic composition.
7. The method of claim 1 , further comprising oxyacetic acid to the Cineraria maritima extract to produce the ophthalmic composition.
8. The method of claim 1 , further comprising apportioning the ophthalmic composition into at least one of a plurality of eye dropper bottles, a plurality of preservative free vials, and a plurality of ocular inserts.
9. The method of claim 1 , further comprising obtaining a Cineraria maritima tincture, and wherein preparing the Cineraria maritima extract comprises preparing the Cineraria maritima extract using the Cineraria maritima tincture.
10. The method of claim 1 , further comprising adding Bendazac to the Cineraria maritima extract to produce the ophthalmic composition.